FBInvestor
Stocks / Aldeyra Therapeutics Inc
Institutional Ownership

Aldeyra Therapeutics Inc

CUSIP 01438T106COMALDXQ1 2026

13D / 13G Filings
29
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
19.4%
Max % of class reported
Institutional Holders
119
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

29 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Perceptive Advisors LLC13G/A7.0%4.19MSEC
2Nov 14, 2025Perceptive Advisors LLC13G/A8.7%5.22MSEC
3Aug 14, 2025Perceptive Advisors LLC13G/A6.8%4.05MSEC
4Apr 7, 2025Perceptive Advisors LLC13G/A8.2%4.88MSEC
5Nov 14, 2024Perceptive Advisors LLC13G/A15.6%9.28MSEC
6Feb 14, 2024Perceptive Advisors LLC13G/A14.6%8.59MSEC
7Feb 13, 2024Vanguard Group Inc13G6.7%3.93MSEC
8Jan 29, 2024Blackrock Inc.13G5.8%3.43MSEC
9Oct 19, 2023Perceptive Advisors LLC13G/A14.7%8.59MSEC
10Oct 4, 2023Knoll Capital Management, LLC13G6.1%3.60MSEC

19 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Aldeyra Therapeutics Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →